Search

New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state

메타 데이터

바이오화학분류
    • 의료용 화학소재
      1. 치료제
      2. 식품첨가제
논문

New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state

학술지

EJNMMI research

저자명

Aarnio, Richard; Kirjavainen, Anna; Rajander, Johan; Forsback, Sarita; Kalliokoski, Kari; Nuutila, Pirjo; Milicevic, Zvonko; Coskun, Tamer; Haupt, Axel; Laitinen, Iina; Haaparanta-Solin, Merja

초록

<P><B>Abstract</B><P>Background<P>Fatty acid uptake can be measured using PET and 14-(<I>R,S</I>)&#x2010;[<SUP>18</SUP>F]fluoro&#x2010;6&#x2010;thia&#x2010;heptadecanoic acid ([<SUP>18</SUP>F]FTHA). However, the relatively rapid rate of [<SUP>18</SUP>F]FTHA metabolism significantly affects kinetic modeling of tissue uptake. Thus, there is a need for accurate chromatographic methods to analyze the unmetabolized [<SUP>18</SUP>F]FTHA (parent fraction). Here we present a new radiometabolite analysis (RMA) method, with comparison to a previous method for parent fraction analysis, and its use in a test-retest clinical study under fasting and postprandial conditions. We developed a new thin-layer chromatography (TLC) RMA method for analysis of [<SUP>18</SUP>F]FTHA parent fraction and its radiometabolites from plasma, by testing stationary phases and eluent combinations. Next, we analyzed [<SUP>18</SUP>F]FTHA, its radiometabolites, and plasma radioactivity from subjects participating in a clinical study. A total of 17 obese or overweight participants were dosed with [<SUP>18</SUP>F]FTHA twice under fasting, and twice under postprandial conditions and plasma samples were obtained between 14 min (mean of first sample) and 72 min (mean of last sample) post-injection. Aliquots of 70 plasma samples were analyzed using both methods, enabling head-to-head comparisons. We performed test-retest and group comparisons of the parent fraction and plasma radioactivity.</P></P><P>Results<P>The new TLC method separated seven [<SUP>18</SUP>F]FTHA radiometabolite peaks, while the previous method separated three. The new method revealed at least one radiometabolite that was not previously separable from [<SUP>18</SUP>F]FTHA. From the plasma samples, the mean parent fraction value was on average 7.2 percentage points lower with the new method, compared to the previous method. Repeated [<SUP>18</SUP>F]FTHA investigations on the same subject revealed reproducible plasma SUV and parent fractions, with different kinetics between the fasted and postprandial conditions.</P></P><P>Conclusions<P>The newly developed improved radio-TLC method for [<SUP>18</SUP>F]FTHA RMA enables accurate parent fraction correction, which is required to obtain quantitative data for modelling [<SUP>18</SUP>F]FTHA PET data. Our test-retest study of fasted and postprandial conditions showed robust reproducibility, and revealed clear differences in the [<SUP>18</SUP>F]FTHA metabolic rate under different study settings.</P></P><P>Trial registration<P>EudraCT No: 2020-005211-48, 04Feb2021; and Clinical Trials registry NCT05132335, 29Oct2021, URL: https://classic.clinicaltrials.gov/ct2/show/NCT05132335.</P></P></P>

발행연도

2024

발행기관

Springer (Biomed Central Ltd.)

ISSN

2191-219x

14

1

페이지

pp.53

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2024-06-13

Export

About

Search

Trend